Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma (Q73132177)
Jump to navigation
Jump to search
scientific article published on 01 March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma |
scientific article published on 01 March 1997 |
Statements
Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma (English)
J S Du Bois
E G Trehu
J W Mier
L Shapiro
M Epstein
M Klempner
C Dinarello
K Kappler
L Ronayne
W Rand
1 March 1997